| Sources | Names Used |
|---|---|
| CTRPv2 | BRD-K13185470 |
| PharmacoGx | BRD-K13185470 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FTL | CTRPv2 | pan-cancer | AAC | 0.22 | 0.004 |
| mRNA | LARS | CTRPv2 | pan-cancer | AAC | -0.2 | 0.004 |
| mRNA | RGMB | CTRPv2 | pan-cancer | AAC | -0.21 | 0.004 |
| mRNA | TEX261 | CTRPv2 | pan-cancer | AAC | 0.22 | 0.004 |
| mRNA | MFSD9 | CTRPv2 | pan-cancer | AAC | 0.22 | 0.004 |
| mRNA | SLC35A2 | CTRPv2 | pan-cancer | AAC | 0.21 | 0.004 |
| mRNA | ASAP1 | CTRPv2 | pan-cancer | AAC | -0.23 | 0.004 |
| mRNA | PAX7 | CTRPv2 | pan-cancer | AAC | -0.23 | 0.004 |
| mRNA | NRN1L | CTRPv2 | pan-cancer | AAC | 0.19 | 0.004 |
| mRNA | FNDC1 | CTRPv2 | pan-cancer | AAC | -0.22 | 0.004 |
